Combination therapy of midodrine and droxidopa for refractory hypotension in heart failure with preserved ejection fraction per a pharmacist's proposal: a case report
Abstract Background Patients with chronic heart failure (CHF) are often treated using many diuretics for symptom relief; however, diuretic use may have to continue despite hypotension development in these patients. Here, we present a case of heart failure with preserved ejection fraction (HFpEF), wh...
Saved in:
Main Authors: | Yuki Asai (Author), Tomoaki Sato (Author), Daisuke Kito (Author), Takanori Yamamoto (Author), Iwao Hioki (Author), Yasuhisa Urata (Author), Yasuharu Abe (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neurogenic orthostatic hypotension – management update and role of droxidopa
by: Vijayan J, et al.
Published: (2015) -
Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study
by: Yuki Asai, et al.
Published: (2020) -
Safety of midodrine in patients with heart failure with reduced ejection fraction: a retrospective cohort study
by: Ming-Ju Wu, et al.
Published: (2024) -
Psychometric validation of a patient-reported single-item assessment of 'Good Day Bad Day' in a neurogenic orthostatic hypotension population treated with droxidopa
by: Clément François, et al.
Published: (2022) -
Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR‐Preserved
by: Andrew J.S. Coats, et al.
Published: (2024)